Comparative Pharmacology
Head-to-head clinical analysis: INTRALIPID 30 versus LIPOSYN III 10.
Peer-Reviewed Evidence
Head-to-head clinical analysis: INTRALIPID 30 versus LIPOSYN III 10.
INTRALIPID 30% vs LIPOSYN III 10%
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Intralipid is a source of calories and essential fatty acids. It provides a mixture of triglycerides, primarily long-chain fatty acids, which are metabolized to generate energy and serve as substrates for lipid membrane synthesis. It also prevents essential fatty acid deficiency.
Liposyn III 10% is an intravenous fat emulsion that provides essential fatty acids (linoleic and linolenic acids) and a source of calories. The triglycerides are hydrolyzed by lipoprotein lipase to free fatty acids and glycerol, which are then utilized for energy production or stored. The emulsion particles are metabolized similarly to endogenous chylomicrons.
Intralipid 30% is administered intravenously as a component of parenteral nutrition. The typical adult dose is 1-2 g/kg/day of fat, not to exceed 60% of total calories. The infusion rate should not exceed 0.11 g/kg/hour (equivalent to 0.37 mL/kg/hour of 30% emulsion).
Intravenous infusion: 500 mL to 1000 mL per day, providing 10% lipid emulsion (100 g fat per liter), infused over 8-12 hours as part of parenteral nutrition, not to exceed 2.5 g fat/kg/day.
None Documented
None Documented
The elimination half-life of Intralipid 30% triglycerides is approximately 30-45 minutes under steady-state conditions in patients with normal lipid metabolism, though this may extend to several hours in critically ill patients or those with impaired clearance. Clinically, the half-life is dose- and infusion-rate-dependent; for continuous infusion, clearance rates are typically 0.1-0.3 g/kg/h, with complete clearance of infused lipids within 4-6 hours after cessation of infusion in healthy adults.
Triglycerides in Liposyn III 10% have a terminal elimination half-life of approximately 0.5 to 1 hour in patients with normal lipid metabolism. In neonates or hepatic impairment, half-life may be prolonged.
Intralipid 30% is a fat emulsion containing soybean oil, egg lecithin, and glycerin, providing essential fatty acids and triglycerides. The lipid particles are metabolized similarly to endogenous chylomicrons, primarily cleared from the bloodstream by lipoprotein lipase in peripheral tissues, releasing free fatty acids which are then utilized or stored. Less than 10% of the administered dose is excreted unchanged in urine; the majority of the lipid components are oxidized to CO2 and water or incorporated into body stores. Biliary/fecal excretion is negligible for the intact emulsion but metabolites may be excreted in bile or feces in small amounts.
Lipids are metabolized via hydrolysis by lipoprotein lipase into free fatty acids and glycerol. Free fatty acids undergo beta-oxidation or re-esterification. Elimination of CO2 via lungs; less than 5% excreted renally as glycerol and other metabolites.
Category C
Category C
Intravenous Fat Emulsion
Intravenous Fat Emulsion